| Identification | Back Directory | [Name]
Petesicatib | [CAS]
1252637-35-6 | [Synonyms]
Petesicatib
2-Pyrrolidinecarboxamide, N-(1-cyanocyclopropyl)-4-[[4-(1-methyl-1H-pyrazol-4-yl)-2-(trifluoromethyl)phenyl]sulfonyl]-1-[[1-(trifluoromethyl)cyclopropyl]carbonyl]-, (2S,4R)- | [Molecular Formula]
C25H23F6N5O4S | [MDL Number]
MFCD31813624 | [MOL File]
1252637-35-6.mol | [Molecular Weight]
603.54 |
| Chemical Properties | Back Directory | [Boiling point ]
818.3±65.0 °C(Predicted) | [density ]
1.62±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO:125.0(Max Conc. mg/mL);207.11(Max Conc. mM) | [form ]
Solid | [pka]
11.51±0.20(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
Petesicatib (RO5459072; RG-7625) is a cathepsin S inhibitor, used in research of immune diseases[1]. | [IC 50]
cathepsin S | [References]
[1] Rubén Alvarez Sánchez, et al. Novel proline derivatives. US20100267722A1 |
|
|